Formulation Development & CTM Manufacturing Services

Similar documents
in full-service contract pharmaceutical development and manufacturing

Next Generation Pharma Solutions

At LATITUDE, we only do one thing, and we do it very well.

NUVISAN GROUP. Our Philosophy

FROM CLINICAL TO COMMERCIAL CUSTOM CAN. An overview of our Development and Manufacturing capabilities

CGMP Requirements for Investigational Products

Pharmaceutical Sciences

Our vision APL

HISTORY AND MILESTONES

Dynamic Future. Reliable Partnership. Company Profile of the Aenova Group

Single Best Way To Deliver. Blow-Fill-Seal Liquid Stick-Pack Powder Stick-Pack Effervescent Global Drug Development Program

AdaptDose, an innovative platform that reduces product development time and costs by 30% or more

GLOBAL QUALITY SOLUTIONS PACKAGE INTEGRITY SEAL INTEGRITY LEAK DETECTION

Contract Manufacturing Services for Pre-filled Syringes

Performance Testing of Novel Dosage Forms

CE 7smart Flow-Through Dissolution System

GUIDELINES FOR INTRODUCING A LOCALLY MANUFACTURED NEW PHARMACEUTICAL PRODUCT ON THE UGANDA MARKET

Headline two lines or three lines. Acino Contract Manufacturing Overview Felix Faupel Global Key Account Manager, Contract Manufacturing

Alkermes Contract Pharma Services

COUNT ON US FROM NON-STERILE TO STERILE FROM GELS AND CREAMS TO OINTMENTS AND AEROSOLS FROM CONCEPT TO COMMERCIALIZATION FROM VIRTUAL TO LARGE PHARMA

Approval Review of Generic Drugs. Office of Generic/OTC Drugs, PMDA Kazuyuki SAITO, Ph.D.

Page 1

Balancing the time, cost and risk of drug development. Christina Gustafsson, PhD Pharm, Formulation Scientist at Pharmaceutical Development, APL

PLANKSTADT EXPERTS TAKING CARE

Guidelines for Pharmaceutical Equivalence Requirements

Industry Perspective on Manufacturing in Early Development

BCS Organizational Chart

GUIDELINE FOR THE STABILITY TESTING

Oral Dosage Formulation Development

Sam Halaby OSD Subject Matter Expert

Bringing ideas to life. Full-service pharmaceutical, nutraceutical and cosmetic contract manufacturing

CONVENIENCE FOR PATIENTS

Extractables and leachables: An Introduction

ASCENDIA PHARMACEUTICALS Aspiring for Better Medicine

Dr. Sheelpriya walde Professor Gurunanak college of pharmacy, Nagpur

CORPORATE PRESENTATION

Formulation Development Services. Your trust is our reward

PAT & Risk-Based Initiatives: Implementation Issues PDA New England - 8 th Dec Cliff Campbell B.E., C.Eng. CC&A Ltd., Cork, Ireland

Intertek Melbourn Company Presentation. MIBio 2016

BEACONS. Exceeding. Expectations. Pharmaceuticals. Quality Pharmaceutical Manufacturing Services

Pharmaceutical Packaging

PG Diploma in Pharmaceutical Quality Assurance onwards- CCII Page 1 of 5

How to Avoid Common Deficiencies in INDs and NDAs. Ramesh Raghavachari, Ph.D. Branch Chief, Branch IX ONDQA/OPS/CDER

A Unique Resource. Pharmaceutical Healthcare Medical Device Nutraceutical VMS Diagnostics

Kollidon The Original Setting new standards in stability, purity and patient safety.

FOOD AND DRUGS AUTHORITY

ADVANCES IN PHARMACEUTICAL INDUSTRY FOR WELLNESS AND SUSTAINABLE HEALTH

A Unique Resource. Pharmaceutical Healthcare Medical Device Nutraceutical VMS Diagnostics

Investigational Product (Pharmaceutical) Management. Sudhakar Bangera MD, MMedSc Program Director, CDSA

Extractables & Leachables. Ophthalmic Drug Products: A Regulatory Perspective Current Industry Challenges and Case Studies

Quality is Our Promise.

Vetter Development Service

BRIEFING 1168 Compounding for Phase I Investigational Studies,

The science of transforming an Active Pharmaceutical Ingredient (API) into a Drug Product (DP) in a specific dosage form.

Partner with the Global Leader in Drug Delivery Systems

Guidance for Industry

Guidance for Industry

2018 EDITORIAL COVERAGE. Connecting the Pharma Industry for 28 Years.

Howida Kamal, Ph.D. Ass. Prof. of Pharmaceutics, Cairo University

Pharmaceutical Packaging

Inspection. Implementation of ICH Q8, Q9, Q10

Contract Packaging Capabilities

Advancing Development & Manufacturing. On target. On topic EDITORIAL CALENDAR.

Derivation and Justification of Safety Thresholds

MARIFARM LLC PRODUCTION ABOUT US

We make drugs smarter

EXPERIENCE AT YOUR SIDE A CDMO THAT DELIVERS ON ITS COMMITMENTS. EXPERIENCE THE BENEFITS WITH AVARA

Complexity of Retention Samples Selection in non-traditional Bioequivalence studies

Development of paediatric formulations - points to consider

USP s Perspective on Drug Product Performance Test

Developing new drug products is very expensive, especially

QbD implementation in Generic Industry: Overview and Case-Study

Evonik Birmingham Laboratories

Formulations for clinical trials in children: possibilities and pitfalls? Robert Ancuceanu, PhD Member of PDCO and FWG

Process Drift: When Do We Detect it? Richard L. Friedman Director, DMPQ CDER/Office of Compliance PQRI Process Drift Workshop December 1, 2010

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel

Key Definitions 6/16/2015

7th Training School on Microencapsulation Strasbourg. Februar 2015 Textmasterformat in Mastervorlage eingeben

SCIENTIFIC DISCUSSION

Institute of Pharmaceutical Technololgy and Biopharmacy University of Pécs

Introduction to CMC Regulatory Affairs

International Journal of Generic Drugs

Pharmaceutical Development (Drug Substance & Drug Product) for Visceral Leishmaniasis candidate DNDI-6148

Brief Introduction of Aburaihan Company Organization Policy Organization Chart Qualified Human Resource Production Department Engineering Department

Design and Dosage Form. Dr. Deny Susanti

FDA S GUIDANCE FOR INDUSTRY ANDAS: STABILITY TESTING OF DRUG SUBSTANCES AND PRODUCTS

Ancona Plant Quality and Innovation 100% MANUFAC TURING SOLUTIONS

Totally Integrated Solutions for Pharmaceutical Industry

RapidFACT: Accelerated Formulation Development for Poorly Soluble Drugs and Modified Release Products

Your partner in the pharmaceutical industry

PHARMACEUTICAL MANUFACTURING

The Benefits of Integrating Metal Detection into Your Product Inspection Program for Consumer Safety. Antoine Dodier & Hitesh Hirani

Early Development Best Practices for Stability- Regulatory Perspective

Providing insight into pharmaceutical formulations

INTRODUCTION TO INDUSTRIAL PHARMACY LAB 1

Maximizing Roller Compaction Benefits with Proper Excipient Selection

ADVANTAGES OF MULTIPARTICULATES (PELLETS):

WHOPAR. SCIENTIFIC DISCUSSION

Pharmaceutical Regulatory Authority GUIDELINE ON APPLICATION FOR REGISTRATION OF UNREGISTERED VETERINARY MEDICINES ALREADY ON THE ZAMBIAN MARKET

Transcription:

Formulation Development & CTM Manufacturing Services VxP Pharma Purdue Research Park 5225 Exploration Drive Indianapolis, IN 46241 Tel: 317.759.2299 Fax: 317.713.2950

VxP Pharmaprovides an extensive range of services and technical support for the development and production of sterile and non-sterile products for clinical trial materials. Oral Solid: Oral Liquid: Topical: Tablets, Effervescent Tablets, Capsules, Granulate Solution, Suspension, Emulsion, Liquid-filled capsule Gel, Cream, Ointment, Lotion Transdermal: Single-layer, Double-layer, Reservoir Sterile Liquid: Solution, Suspension, Lyophilized, Emulsion Ophthalmic: Solution, Suspension, Ointment Combination: Multi-layer Tablet, Multi-particulate Drug Delivery Other: Potent, Cytotoxic & Scheduled Compounds (CII-CV)

Development Services: Drug Characterization Preformulation Studies Formulation Development Analytical Development Release & Stability Testing Services Overview Manufacturing Services: Clinical Trial Materials GMP and Non-GMP Production Niche Commercial Manufacturing

Analytical Services Experienced Professionals in Analytical Chemistry Method development, Qualification and Validation Raw Material Testing (select) Cleaning Analysis/Verification Full Release & Stability Testing Stability Storage ICH Conditions 25 o C/60%RH, 30 o C/65%RH, 40 o C/75%RH Custom conditions also available

Formulation Services Solids Tablets, Capsules, Modified Release, Granules, Pellets, Coatings Semi-Solids Creams, Gels, Ointments, Lotions Dispersed Systems Emulsions & Suspensions Liquids/Solutions Oral, Ophthalmic, Parenteral Transdermal

Formulation Services We can provide the facilities and expertise to work with your most challenging drug formulation issues: Solubility issues Unstable compounds Innovative delivery options Low dose formulations Controlled drugs (CII CV) High potency compounds Cytotoxic compounds

Formulation Services Our scientists have years of experience and the necessary equipment to develop a wide-range of dosage forms: Solubilizing water-insoluble drugs Stabilizing unstable molecules through formulation & excipient selection Taste masking/flavoring Bioavailability enhancement Excipient selection and Compatibility studies Particle size reduction Formulation screening & Feasibility studies

Clinical Trial Materials (CTM) Manufacturing We offer technical resources, capacity, flexibility, and the expertise to develop and manufacture virtually any clinical dosage form with strict quality compliance. Processes optimized for future commercial scale-up Pharmaceuticalmanufacturing in support of Phase I-IIIclinical supply needs for solids, liquids, semi-solids, topicals, and transdermals. Including packaging and labeling in: Blister & Strip Packs Bottles, Vials & Syringes Tubes Sachets & Pouches

Clinical Trial Materials (CTM) Manufacturing Manufacture of matching placebo for clinical studies. In support of blinded clinical studies, we provide batch manufacturing of matching placebo supplies, as well as supplies for comparator studies. Process qualification and cleaning verification VxP Pharma follows the FDA guidance and incorporates appropriate elements of process validation for the manufacture of human drug products. Full cgmp compliance, accountability and document traceability Compliant with Title 21 CFR Part 11, all data 100% inspected and quality audited to ensure full cgmp manufacturing compliance.

Dosage Forms Contract Manufacturing Services API in Capsule/Bottles Tablets Composite, Bi-layer, Tri-layer Coated Capsules Liquid, Solid Coated Over-encapsulation Liquids Solution, Topical, Emulsion, Suspension, Parenteral Transdermals

Contract Manufacturing Services Manufacturing Processes Fluid Bed Granulation (Wurster& Top Spray) High/Low Shear Granulation Roller Compaction Direct Compression Tabletting Encapsulation Tablet/Particle Coating (Aqueous& Solvent) Ophthalmic/Otic Solutions/Ointments Contact Us Today for details on Sterile Process Development

Contract Manufacturing Services Packaging & Labeling Bulk, Bottles, Sachets, Tubes, Vials, Blisters, Syringes Glass, HDPE, PET, PS, and Protective Coloring Labeling Single Panel, Booklet, Blinded, Randomized, Multi-language Coated Tamper Sealing, Desiccant, Child Resistant Secondary Packaging Cartons Wallets & Dosepacks Complex kits

Contract Manufacturing Services Technology Transfer Extensive experiencewith Technology Transfer process from concept to commercialization transfer packages. Our technology transfer experts provide in-depth experience with: Site Transfer Equipment Selection and Validation (IQ, OQ, PQ) Existing Process Optimizations (Lean and Six Sigma) Batch Record Development Validation Protocol Preparation and Execution SOP Development and Method Development Alternate Raw Material Evaluation and Re-formulation Scale-up Assistance from feasibility to commercialization

Analytical & Bioanalytical Services VxP Pharmaprovides an extensive range of analytical services and technical support for method development, validation and testing for multiple pharmaceutical and biopharmaceutical applications. API Testing Product Development Testing CMC/Compendial Testing

Discover The Benefits Our scientists have expertise in virtually every dosage form giving us the advantage to quickly and effectively create solutions to formulation issues. Ourstaff has over 200+ years of combined experience in contract pharmaceutical development. Ourmanufacturing facilities and development teams are designed to provide you the greatest flexibility while maintaining quality throughout the entire project.

THANK YOU For additional information: VxP Pharma www.vxppharma.com Phone: 317.759.2299 Email: info@vxppharma.com